Evidence for the Efficacy of Bright Light Therapy for Bipolar Depression

Basit Öğe Kaydı
dc.authoridLam, Raymond W/0000-0001-7142-4669
dc.authoridYoshiike, Takuya/0000-0002-6071-8167
dc.authoridCamardese, Giovanni/0000-0002-8139-9230
dc.authoridYorguner, Nese/0000-0001-8411-0466
dc.authoridBenedetti, Francesco/0000-0003-4949-856X
dc.authoridMartiny, Klaus/0000-0002-7317-5958
dc.authoridwu, joseph/0000-0001-7765-3112
dc.authorwosidDallaspezia, Sara/AAB-7745-2019
dc.authorwosidKasper, Stefan/I-4521-2015
dc.authorwosidLam, Raymond W/D-2529-2013
dc.authorwosidCaliyurt, Okan/ABE-7339-2020
dc.authorwosidVeale, David M/F-5670-2010
dc.authorwosidYoshiike, Takuya/AAL-5150-2020
dc.authorwosidCamardese, Giovanni/AAC-1840-2022
dc.contributor.authorBenedetti, Francesco
dc.contributor.authorAvery, David H.
dc.contributor.authorBauer, Michael
dc.contributor.authorBunney, William E.
dc.contributor.authorCaliyurt, Okan
dc.contributor.authorCamardese, Giovanni
dc.contributor.authorColombo, Cristina
dc.date.accessioned2024-06-12T11:19:51Z
dc.date.available2024-06-12T11:19:51Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAngelini; AOP Orphan Pharmaceuticals AG; AstraZeneca; Eli Lilly; Janssen; KRKA-Pharma; Lundbeck; Neuraxpharm; Pfizer; Pierre Fabre; Schwabe; Servier; BC Leading Edge Foundation; Brain Canada; Canadian Institutes of Health Research; Canadian Network for Mood and Anxiety Treatments; Movember Foundation; St. Jude Medical; University Health Network Foundation; Vancouver Coastal Health Research Institute; VGH Foundationen_US
dc.description.sponsorshipDr. Avery has written articles for UpToDate. Dr. Henriksen is a shareholder in Chrono Chrome AS. Dr. Kasper received grants, research support, consulting fees, and/or honoraria within the last 3 years from Angelini, AOP Orphan Pharmaceuticals AG, AstraZeneca, Eli Lilly, Janssen, KRKA-Pharma, Lundbeck, Neuraxpharm, Pfizer, Pierre Fabre, Schwabe, and Servier. Dr. Lam has received speakers honoraria from the Canadian Network for Mood and Anxiety Treatments, the Canadian Psychiatric Association, Lundbeck, and Pfizer; he has been a consultant for or served on advisory boards of Akili, Allergan, the Asia-Pacific Economic Cooperation, the Canadian Depression Research and Intervention Network, the Canadian Network for Mood and Anxiety Treatments, the CME Institute, Janssen, Lundbeck, Medscape, Otsuka, and Pfizer; he has received research funds (through the University of British Columbia) from the BC Leading Edge Foundation, Brain Canada, the Canadian Institutes of Health Research, the Canadian Network for Mood and Anxiety Treatments, Janssen, Lundbeck, the Movember Foundation, Pfizer, St. Jude Medical, the University Health Network Foundation, the Vancouver Coastal Health Research Institute, and the VGH Foundation; he owns a patent related to the Lam Employment Absence and Productivity Scale (LEAPS); he receives royalties from Cambridge University Press, Informa Press, and Oxford University Press; and he owns stock in Mind Mental Health Technologies. Dr. Winkler has received lecture fees from Angelini, Lundbeck, and Pfizer. The other authors report no financial relationships with commercial interests.en_US
dc.identifier.doi10.1176/appi.ajp.2018.18020231
dc.identifier.endpage906en_US
dc.identifier.issn0002-953X
dc.identifier.issn1535-7228
dc.identifier.issue9en_US
dc.identifier.pmid30173556en_US
dc.identifier.scopus2-s2.0-85052824264en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage905en_US
dc.identifier.urihttps://doi.org/10.1176/appi.ajp.2018.18020231
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25371
dc.identifier.volume175en_US
dc.identifier.wosWOS:000443266600014en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAmer Psychiatric Publishing, Incen_US
dc.relation.ispartofAmerican Journal Of Psychiatryen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSafetyen_US
dc.subjectManiaen_US
dc.titleEvidence for the Efficacy of Bright Light Therapy for Bipolar Depressionen_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu